| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.058 | 0.3 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.3 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.3 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |